p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma

[1]  Francesco Spagnolo,et al.  Uveal melanoma. , 2012, Cancer treatment reviews.

[2]  D. Spiller,et al.  PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells , 2011, Cell Death and Disease.

[3]  D. Spiller,et al.  P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma , 2009, Journal of cellular and molecular medicine.

[4]  C. Eng,et al.  Targeted therapy for uveal melanoma. , 2008, Cancer treatment reviews.

[5]  N. Gruis,et al.  Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma. , 2008, Investigative ophthalmology & visual science.

[6]  M. Lindstrom,et al.  Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. , 2008, Investigative ophthalmology & visual science.

[7]  A. Yang,et al.  p63 protects the female germ line during meiotic arrest , 2006, Nature.

[8]  I. Grierson,et al.  Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. , 2006, Experimental eye research.

[9]  D. Lohmann,et al.  Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3. , 2006, Experimental eye research.

[10]  A. Balmain,et al.  p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo , 2005, Oncogene.

[11]  Rebecca A. Ihrie,et al.  A New Perp in the Lineup: Linking p63 and Desmosomal Adhesion , 2005, Cell cycle.

[12]  Young Sun,et al.  Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma. , 2005, Investigative ophthalmology & visual science.

[13]  A. Yang,et al.  Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. , 2005, Cancer cell.

[14]  Rebecca A. Ihrie,et al.  Perp Is a p63-Regulated Gene Essential for Epithelial Integrity , 2005, Cell.

[15]  F. Alt,et al.  p63 and p73 are not required for the development and p53-dependent apoptosis of T cells. , 2004, Cancer cell.

[16]  T. Jacks,et al.  Multiple response elements and differential p53 binding control Perp expression during apoptosis. , 2003, Molecular cancer research : MCR.

[17]  T. Kivelä,et al.  Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.

[18]  A. Yang,et al.  A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism , 2002, Molecular and Cellular Biology.

[19]  K. Tsai,et al.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage , 2002, Nature.

[20]  N. Little,et al.  Hdmx and Mdm2 can repress transcription activation by p53 but not by p63 , 2001, Oncogene.

[21]  S. Berberich,et al.  Regulation of p63 function by Mdm2 and MdmX. , 2001, DNA and cell biology.

[22]  O. Larsson,et al.  Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. , 2001, Investigative ophthalmology & visual science.

[23]  J. Harbour,et al.  Deregulation of the Rb and p53 pathways in uveal melanoma. , 2000, American Journal of Pathology.

[24]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[25]  U. Weidle,et al.  Identification of THW, a putative new tumor suppressor gene. , 2000, Anticancer research.

[26]  S. Lowe,et al.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. , 2000, Genes & development.

[27]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[28]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[29]  A. Foss,et al.  c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma , 1999, The British journal of ophthalmology.

[30]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[31]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[32]  W. Kaelin,et al.  p73 is a human p53-related protein that can induce apoptosis , 1997, Nature.

[33]  D. Albert.  The ocular melanoma story. LIII Edward Jackson Memorial Lecture: Part II. , 1997, American journal of ophthalmology.

[34]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[35]  I. McLean,et al.  Uveal melanoma , 1997, Cancer.

[36]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[37]  A. Hagemeijer,et al.  Establishment and characterization of primary and metastatic uveal melanoma cell lines , 1996, International journal of cancer.

[38]  K. Kishore,et al.  p53 gene and cell cycling in uveal melanoma. , 1996, American journal of ophthalmology.

[39]  P T de Jong,et al.  Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. , 1995, The American journal of pathology.

[40]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[41]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[42]  W. Kaelin,et al.  p73 is a simian [correction of human] p53-related protein that can induce apoptosis. , 1997, Nature.